Congressional Panel Approves Bill To Streamline Marijuana And Psychedelics Research While Ramping Up Fentanyl Criminalization

Marijuana Moment
By Kyle JaegerMar 27, 2023, 6:36 pm352 ptsTop
A congressional committee has approved a bill that aims to ramp up criminalization for fentanyl-related substances, while also streamlining research into Schedule I drugs like marijuana and certain psychedelics. The legislation, sponsored by Rep. Morgan Griffith (R-VA), passed the House Energy & Commerce…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Independent cannabis operators versus MSOs? Consumers don’t walk the talk 69

Kentucky Medical Marijuana Growers Will Be ‘Putting Seed In The Ground Really Soon,’ Governor Says 69

Why Are THC-P Products Gaining Significant Hype From The Youth? 65

California Cannabis Excise Tax Hike Takes Effect as Consumers Face Mounting Cost-of-Living Crisis 60

New Hampshire Bill To Ease Psilocybin Penalties Advances Through House But Is Tabled In Senate 60

Doctors Group Launches Campaign Empowering More Healthcare Professionals To Join Drug Decriminalization Movement 57

What’s Changed Since Connecticut Legalized Adult-Use Marijuana 4 Years Ago? 53

Emergency Town Hall in Flowery Branch, GA to Address Federal Threats to Medical Cannabis Protections 52

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.